Factors related to microbiological isolates in patients with Non Cystic-Fibrosis Bronquiectasis (Non-CFBQ)
J. Hernandez Borge (Badajoz, Spain), M. Benitez-Cano Gamonoso (Badajoz, Spain), M. Antona Rodriguez (Badajoz, Spain), M. Gomez Vizcaino (Badajoz, Spain), P. IñIgo Naranjo (Badajoz, Spain), P. Cordero Montero (Badajoz, Spain), A. Sanz Cabrera (Badajoz, Spain), J. Gutierrez Lara (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), K. El Boutaibi Faiz (Badajoz, Spain), F. Marquez Perez (Badajoz, Spain)
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Hernandez Borge (Badajoz, Spain), M. Benitez-Cano Gamonoso (Badajoz, Spain), M. Antona Rodriguez (Badajoz, Spain), M. Gomez Vizcaino (Badajoz, Spain), P. IñIgo Naranjo (Badajoz, Spain), P. Cordero Montero (Badajoz, Spain), A. Sanz Cabrera (Badajoz, Spain), J. Gutierrez Lara (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), K. El Boutaibi Faiz (Badajoz, Spain), F. Marquez Perez (Badajoz, Spain). Factors related to microbiological isolates in patients with Non Cystic-Fibrosis Bronquiectasis (Non-CFBQ). 2666
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Factors affecting treatment success in community acquired pneumonia (CAP) Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia pneumonia: 10 years experience of single center Source: International Congress 2019 – Airway infection in COPD Year: 2019
Change in the susceptibility pattern of Streptococcus pneumoniae (SP) and risk factors (RF) for antibiotic resistance (AR) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 546s Year: 2003
Clinical outcomes of patients with HAP/VAP due to PVL(+) vs. PVL(-) MRSA: Results from the IMPACT-HAP study Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Epidemiological and clinical features of non tuberculous mycobacteria infection (NTM) in a five-year single centre experience Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016
Dynamic of resistance of streptococcus pneumoniae strains from patients with CAP in theritary tertyary hospital: 10 years prospective study Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016
Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005
High carbapenem resistance in gram negative bacterial isolates: An outcome study Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Clinical features, outcome and factors associated with mortality in patients with Nocardia pneumonia Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012
Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trials Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014
Clinical, radiological and bacteriological features in geriatric tuberculosis (TB) patients (pts) - initial treatment and outcome Source: Eur Respir J 2002; 20: Suppl. 38, 363s Year: 2002
Clinical impact of a prediction score for drug-resistance in community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Laboratory findings, physical and clinical features of mycoplasma pneumoniae infections. Analysis of 21 cases Source: Eur Respir J 2004; 24: Suppl. 48, 716s Year: 2004
Differences in prognostic factors and outcome in community-acquired pneumonias (CAP) caused by viral pathogens (VP) or streptococcus pneumoniae (SP) Source: Eur Respir J 2001; 18: Suppl. 33, 542s Year: 2001
Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010
Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Factors affecting tuberculosis treatment: the beliefs of patients Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
Clinical characteristics of 11 cases of pulmonary abscess in children Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013